Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant hurdles for many patients. A new viewpoint paper published in the Journal of… read more.
Abbott announced it has received CE Mark for the Amulet 360 Left Atrial Appendage (LAA) Occluder, a next-generation device designed to reduce risk of stroke in patients with… read more.
Royal Philips and Imricor Medical Systems announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration combines Philips’ 1.5T MRI platform… read more.
Abbott announced FDA authorization of its Libre Duo 10 Day system, the world’s first dual glucose-ketone sensing technology. The new biowearable is designed to alert people living with… read more.
A multicenter randomized clinical trial led by researchers from the Pain Outcomes Lab at Wake Forest University School of Medicine found that high-frequency spinal cord stimulation significantly reduced pain and… read more.
Robot-assisted knee replacement surgery is more precise than a surgeon on their own, but does not currently lead to improvements in patient outcomes, according to the RACER-Knee trial,… read more.
Automatic crash notification (ACN) systems should become a standard safety feature in every new vehicle, like seat belts and air bags, according to a new paper by members of the American… read more.
GE HealthCare recently achieved CE Mark for Photonova Spectra, an advanced photon-counting computed tomography (PCCT) system with the company’s proprietary Deep Silicon detector technology. The regulatory milestone expands… read more.
University of Birmingham scientists have developed a new material that changes from a gel to a liquid-like state under ultraviolet light and can be rebuilt using heat or… read more.
Wearable sensors coupled with AI can generate blood pressure readings nearly as well as the invasive and risky arterial lines relied on in intensive care units and operating… read more.
A real-time prescription benefit (RTPB) tool did not change overall prescription fill rates but did increase fill rates for high-cost medications, according to a post hoc analysis of… read more.
Johnson & Johnson announced U.S. 510(k) regulatory clearance for MONARCH QUEST 3, the latest software update for the MONARCH Platform. The update reflects the company’s continued commitment to… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
